Strategies for augmentation of SSRI treatment: A survey of an academic psychopharmacology practice

被引:20
作者
Mischoulon, D [1 ]
Fava, M [1 ]
Rosenbaum, JF [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Psychiat, Outpatient Div, Boston, MA 02114 USA
关键词
D O I
10.3109/10673229909017210
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
[No abstract available]
引用
收藏
页码:322 / 326
页数:5
相关论文
共 28 条
[1]   Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy [J].
Bodkin, JA ;
Lasser, RA ;
Wines, JD ;
Gardner, DM ;
Baldessarini, RJ .
JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (04) :137-145
[2]   Non response to citalopram in depressive patients: Pharmacokinetic and clinical consequences of a fluvoxamine augmentation [J].
Bondolfi, G ;
Chautems, C ;
Rochat, B ;
Bertschy, G ;
Baumann, P .
PSYCHOPHARMACOLOGY, 1996, 128 (04) :421-425
[3]  
Byrne S, 1997, PSYCHIAT SERV, V48, P835
[4]   LITHIUM AUGMENTATION IN SERTRALINE-RESISTANT DEPRESSION - A PRELIMINARY DOSE-RESPONSE STUDY [J].
DINAN, TG .
ACTA PSYCHIATRICA SCANDINAVICA, 1993, 88 (04) :300-301
[5]   CONTINUATION AND MAINTENANCE TREATMENTS OF MAJOR DEPRESSIVE DISORDER [J].
FAVA, M ;
KAJI, J .
PSYCHIATRIC ANNALS, 1994, 24 (06) :281-290
[6]  
FAVA M, 1994, AM J PSYCHIAT, V151, P1372
[7]   Definition and epidemiology of treatment-resistant depression [J].
Fava, M ;
Davidson, KG .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 1996, 19 (02) :179-&
[8]   Seizures associated with bupropion and SSRI co-therapy [J].
Gerner, RH ;
Kaufman, KR ;
Rosen, R .
BIOLOGICAL PSYCHIATRY, 1998, 43 :99S-99S
[9]  
Hansgen K D, 1994, J Geriatr Psychiatry Neurol, V7 Suppl 1, pS15, DOI 10.1177/089198879400700106
[10]   (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine [J].
Hjorth, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 303 (03) :183-186